Phenotypic and Genotypic Characterization of Patients With Dysmetabolism in Greenland
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1000 participants.
Also called NCT06264427
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 1,000 participants
- Registry
-
NCT06264427
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Greenland
- Registry status
- Recruiting
Technical summary
Registry record NCT06264427. Allocation not applicable; no masking; primary purpose treatment. Start 2022-07-15 (actual); primary completion 2025-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Phenotypic and Genotypic Characterization of Patients With Dysmetabolism in Greenland
- Condition
- Diabetes Mellitus, Type 2
- Condition
- Obesity, Morbid
- Condition
- Obstructive Sleep Apnea
- Condition
- MODY
- Condition
- Diabetic Retinopathy
- Condition
- Diabetic Neuropathies
- Intervention (Genetic)
- Whole genome sequencing
- Intervention (Diagnostic test)
- VAGUS
- Intervention (Diagnostic test)
- NightOwl
- Intervention (Device)
- CPAP
- Lead sponsor
- Steno Diabetes Center Greenland
- Collaborator
- Zealand University Hospital
- Collaborator
- University of Copenhagen
Record details
- Record id
cardio:ct-nct06264427- Content hash
3a832ee829b064d7b1284291be8fc11828e029b71df8dd372cc6d2c697d0512e